| 000 | 01492 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516011858.0 | ||
| 264 | 0 | _c20110321 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1471-2407 | ||
| 024 | 7 |
_a10.1186/1471-2407-10-604 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTeschendorff, Andrew E | |
| 245 | 0 | 0 |
_aImproved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules. _h[electronic resource] |
| 260 |
_bBMC cancer _cNov 2010 |
||
| 300 |
_a604 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xclassification |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aEstrogen Receptor alpha _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmune System |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTh1 Cells _xmetabolism |
| 650 | 0 | 4 |
_aTh2 Cells _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGomez, Sergio | |
| 700 | 1 | _aArenas, Alex | |
| 700 | 1 | _aEl-Ashry, Dorraya | |
| 700 | 1 | _aSchmidt, Marcus | |
| 700 | 1 | _aGehrmann, Mathias | |
| 700 | 1 | _aCaldas, Carlos | |
| 773 | 0 |
_tBMC cancer _gvol. 10 _gp. 604 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2407-10-604 _zAvailable from publisher's website |
| 999 |
_c20349506 _d20349506 |
||